Qiu-li Zhang

Nephrology · 2008

A researcher in the Science corpus: 1 paper; trusts 5 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom Qiu-li Zhang trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Josef Coresh
  2. A. Levey
  3. B. Astor
  4. Tom Greene

Papers from Qiu-li Zhang's perspective

Ordered by how strongly the researchers Qiu-li Zhang trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. (American Journal of Kidney Diseases)
  2. Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate (Annals of Internal Medicine)
  3. Prevalence of chronic kidney disease in the United States. (Journal of the American Medical Association (JAMA))
  4. National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification (Annals of Internal Medicine)
  5. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. (Archives of Internal Medicine)
  6. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. (American Journal of Kidney Diseases)
  7. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. (Journal of the American Society of Nephrology)
  8. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). (Kidney International)
  9. Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. (Kidney International)
  10. Renal Insufficiency as a Predictor of Cardiovascular Outcomes and the Impact of Ramipril: The HOPE Randomized Trial (Annals of Internal Medicine)

Their papers